.

Nick Jonas And Bayer Diabetes Care Team Up To Give Back. Simply Win

05/05/2010
.
Nick Jonas has teamed with Bayer Diabetes Care for a new contest, "Give Back. Simply Win." The contest will shine a spotlight on people with diabetes who are making a difference in their local communities.

Three grand prize winners will meet international singing sensation Nick Jonas and Bayer will donate $5,000 to three not-for-profit charitable causes, one selected by each winner.

Bayer's "Give Back. Simply Win." contest was designed to reward people with diabetes for their charitable efforts. Entering the contest is simple; it is open to people with diabetes in three age categories: 6 to 12, 13 to 17 and 18+ years.

Contestants can visit www.NicksSimpleWins.com and answer three questions about their charitable efforts. Nick and a team of judges will select one grand prize winner from each of the three age categories. The contest begins today and entries will be accepted until August 5, 2010.

Nick Jonas, now 17, was diagnosed with type 1 diabetes when he was 13. Since he publicly announced his diagnosis, he has become widely recognized not only for his musical talents, but also for his efforts to inspire people with diabetes and give back to fans that inspire him. Nick knows how important good diabetes management is and one of the ways he spreads that message is through his partnership with Bayer Diabetes Care.

"One of the things we've been so impressed with is how much people with diabetes are doing for their communities," said Nick. "Bayer and I hope that through this contest we can call attention to them and thank people with diabetes who support and inspire others, whether it be through volunteering or fundraising."


Click here to read today's full Day in Pop report

Preview and Purchase Nick Jonas CDs

Nick Jonas MP3 Downloads


advertisement




Day In Rock Reports


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2019 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.